Thanks for that advice Tilly and Coit. Look yes this stock is a bit of a punt let's face it. But saying that there have been some massive volumes and given the drugs potential if approved it could well follow in the footsteps of SRX. Many seem to think they will get this through in October and have a lot of faith in the new CEO. It will be very interesting to see how it all plays out, but if we see a rally after the FOMC on Friday I'm thinking it could hit 16 cents.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |